Lilly is a global healthcare leader committed to improving lives through groundbreaking discovery, scientific excellence, and innovation. With over 145 years of experience, Lilly has built a strong legacy of developing high-quality, trusted medicines that address some of the world’s most pressing health challenges. The company focuses on advancing treatments in areas such as diabetes, oncology, immunology, and neuroscience—improving disease understanding, prevention, and management.

Headquartered in Indianapolis, Indiana, Lilly operates in more than 120 countries with a global team dedicated to putting patients at the center of everything they do. Its mission is to make life better for people worldwide by delivering impactful medicines, promoting health equity, and supporting communities in need.

Lilly also invests in research, partnerships, and innovative healthcare solutions to expand access to its therapies. Through science, compassion, and a deep commitment to those they serve, Lilly continues to shape the future of healthcare and drive better global health outcomes.

Bayer is a Life Science company with over 150 years of history and expertise in health care and agriculture. With our innovative products, we help address some of today’s major global challenges.

Our vision is to make better life a reality for billions of people through everyday healthcare. With a broad global presence and a trusted portfolio of leading brands, we empower individuals to get well, be well, and stay well—caring for themselves and their loved ones.

We touch billions of lives by providing safe, effective, and convenient health solutions that treat minor illnesses and support better daily living.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

Haleon is a world-leading consumer health company with a clear purpose — to deliver better everyday health with humanity.

Our trusted and science-based brands span six key categories and are available in more than 170 countries worldwide. They play a vital role in improving everyday health for millions of people, in a sector that continues to grow and become more relevant than ever.

Established in 1994, Tabuk Pharmaceuticals is a leading Saudi pharmaceutical company operating in 17 countries across the Middle East and Africa.

With advanced manufacturing sites in Tabuk, Dammam, Sudan, and Algeria, Tabuk Pharmaceuticals manufactures and distributes a wide range of pharmaceutical products, addressing various therapeutic fields, including central nervous, cardiovascular, respiratory, musculoskeletal, gastrointestinal systems, and anti-infectives.

With over 2,400 qualified employees, Tabuk Pharmaceuticals’ commitment to quality and innovation has enabled the company to establish itself as a key player in the region's pharmaceutical industry.

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands. P&G Health, the health care division of P&G company, combines breakthrough Science with deep patient and consumer understanding to deliver trusted, quality, recommended superior products that empower people to live healthier and more vibrant lives. The P&G Health portfolio includes leading brands in Nerve Care with Neurobion®, Omega 3 supplementation with Seven Seas®, pregnancy with Femibion®, Respiratory with Vicks® and Oral Care with Crest® and Oral-B

Opella is a global self-care company with the third-largest portfolio in the Over-The-Counter (OTC) and Vitamins, Minerals & Supplements (VMS) market. Its mission is to simplify self-care for over half a billion consumers worldwide. With 100 trusted brands, a team of 11,000 professionals, 13 manufacturing sites, and 4 innovation centers, Opella drives science-based health solutions. Headquartered in France, it produces renowned brands such as Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale, and Mucosolvan. As a certified B Corp, Opella is committed to advancing global health while promoting sustainability, making healthier living accessible for people and contributing positively to the planet

AbbVie is a global biopharmaceutical company committed to developing innovative medicines that address some of the world’s most serious health challenges. With a strong focus on immunology, oncology, neuroscience, and eye care, AbbVie combines advanced science with deep clinical expertise to improve patient outcomes. Its diverse portfolio includes the renowned Allergan Aesthetics division, offering treatments that enhance quality of life and support holistic patient care. AbbVie prioritizes a patient-centered approach, striving to deliver transformative therapies that make a meaningful impact on lives around the world. Through continued research, development, and collaboration, AbbVie aims to push the boundaries of medicine, address unmet medical needs, and contribute to sustainable healthcare advancements. The company’s dedication to innovation and integrity drives its mission to improve health and create a better future for patients globally.

Novo Nordisk is a global healthcare company founded in 1923 and headquartered near Copenhagen, Denmark. With a strong legacy in diabetes care, our purpose is to drive change to defeat serious chronic diseases. We focus on pioneering scientific breakthroughs, expanding access to medicines, and working to prevent and ultimately cure the diseases we treat. Today, Novo Nordisk employs over 77,000 people across 80 offices worldwide, and our products are available in 170 countries. Our innovative treatments are helping millions of people living with diabetes, obesity, and rare blood and endocrine disorders. Through our commitment to science, access, and sustainability, we aim to improve global health and make a lasting impact on patients' lives. Our vision is to build a healthier future by transforming the way chronic diseases are treated and managed.

Hikma helps put better health within reach every day for  millions of people around the world. For more than 45  years, we've been creating high-quality medicines and  making them accessible to the people who need them. Headquartered in the UK, we are a global company with a  local presence across the United States (US), the Middle  East and North Africa (MENA) and Europe, and we use  our unique insight and expertise to transform cutting-edge  science into innovative solutions that transform people's  lives. We're committed to our customers, and the people  they care for, and by thinking creatively and acting  practically, we provide them with a broad range of  branded and non-branded generic medicines. Together, our 9,500 colleagues are helping to shape a  healthier world that enriches all our communities. We are  a leading licensing partner, and through our venture  capital arm, are helping bring innovative health  technologies to people around the world. For more  information, please visit: www.hikma.com